For appropriate patients on a multi-tablet darunavir regimen
Simplify the Regimen With SYMTUZA®

SYMTUZA® is the only STR formulation of darunavir and the smallest darunavir coformulation available1-3


(Pills Are Not Actual Size)
TAF=tenofovir alafenamide; STR=single tablet regimen.
References: 1. SYMTUZA® [package insert]. Titusville, NJ: Janssen Therapeutics, Division of Janssen Products, LP. 2. Data on file. Janssen Therapeutics, Division of Janssen Products, LP. 3. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Updated January 20, 2022. Accessed March 8, 2022. https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv/whats-new-guidelines